Literature DB >> 970439

Goiter formation following prostaglandin administration in rats.

A Lupulescu.   

Abstract

Prostaglandins (PGE1 and PGE2) induced a hyperplastic microfollicular goiter with a high radioiodine (131I) thyroid uptake, increased endocytosis, a heavy autoradiographic (125I) reaction, and a moderate increase of thyroid hormones (T4, T3), thyroxine-binding globulin (TGB), and thyrotropin (TSH) concentrations in adult rats. Ultrastructurally, both prostaglandins (E1 and E2) markedly stimulated the thyroid cell activity and increased the number of pseudopodia, the size of colloid and dense granule populations, and the number of polysomes. Conversely, a hypofunction of thyroid glands with low radioiodine (131I) thyroid uptake, a decreased autoradiographic (125I) reaction, and a moderate decrease in T4, T3, TGB, and TSH concentrations were observed following prostaglandin F 2alpha. Ultrastructurally, a decrease in size of the colloid and dense granule population and the number of degenerative mitochondria occurred infollicular cells. An intense hyperplasia of parafollicular (C) cells, with abundant population of characteristic dense granules, could be seen in PGF 2alpha-treated rats. A marked decrease of radioiodine (131I) uptake, endocytosis, and autoradiographic (125I) reaction and a sharp decline in T4, T3, and TBG were observed in hypophysectomized and chronically prostaglandin-treated rats. Light and electron microscopy revealed signs of an advanced thyroid hypofunction with flat cuboidal cells, reduced microvilli, scarce endoplasmic reticulum, and few dense droplets. The present findings demonstrate that the chronic administration of prostaglandins exerts significant effects of thyroid gland and goiter formation (goitrogenesis), radioiodine metabolism, and hormone synthesis, and that these effects are mediated by TSH secretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970439      PMCID: PMC2032556     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  Effects of prostaglandin E1, ethanol and TSH on the adenylate cyclase activity of beef thyroid plasma membranes and cyclic AMP content of dog thyroid slices.

Authors:  K Mashiter; G D Mashiter; J B Field
Journal:  Endocrinology       Date:  1974-02       Impact factor: 4.736

2.  Role of prostaglandin in thyrotropin action on thyroid.

Authors:  S Sato; M Szabo; K Kowalski; G Burke
Journal:  Endocrinology       Date:  1972-02       Impact factor: 4.736

3.  In vitro effects of prostaglandins on thyroid gland metabolism.

Authors:  J Field; A Dekker; U Zor; T Kanenko
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

4.  Effects of prostaglandins on basal and stimulated thyroid function.

Authors:  G Burke
Journal:  Am J Physiol       Date:  1970-05

5.  Homologous radioimmunoassay of thyrotrophin in rat plasma.

Authors:  J D Kieffer; B D Weintraub; W Baigelman; S Leeman; F Maloof
Journal:  Acta Endocrinol (Copenh)       Date:  1974-07

6.  Culture of enzymatically dispersed pituitary cells: functional validation of a method.

Authors:  W Vale; G Grant; M Amoss; R Blackwell; R Guillemin
Journal:  Endocrinology       Date:  1972-08       Impact factor: 4.736

7.  Determination of thyroxine-binding globulin. A simplified procedure utilizing dextran-coated charcoal.

Authors:  R C Roberts; T F Nikolai
Journal:  Clin Chem       Date:  1969-12       Impact factor: 8.327

8.  Measurement of plasma and tissue triiodothyronine concentration in the rat by radioimmunoassay.

Authors:  I Nejad; J Bollinger; M A Mitnick; P Sullivan; S Reichlin
Journal:  Endocrinology       Date:  1975-03       Impact factor: 4.736

9.  High-resolution autoradiography. I. Methods.

Authors:  L G CARO; R P VAN TUBERGEN; J A KOLB
Journal:  J Cell Biol       Date:  1962-11       Impact factor: 10.539

10.  Thyroxine transport in thyrotoxicosis and hypothyroidism.

Authors:  M Inada; K Sterling
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.